1037 related articles for article (PubMed ID: 27879219)
21. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
[TBL] [Abstract][Full Text] [Related]
22. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
[TBL] [Abstract][Full Text] [Related]
23. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
24. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
25. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
[TBL] [Abstract][Full Text] [Related]
26. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
[TBL] [Abstract][Full Text] [Related]
27. Generation of induced pluripotent stem cell (iPSC) line from a 36-year-old Charcot-Marie-Tooth disease patient with GJB1 mutation (CMTX).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 May; 21():9-12. PubMed ID: 28677541
[TBL] [Abstract][Full Text] [Related]
28. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
29. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
[TBL] [Abstract][Full Text] [Related]
30. Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.
Koh S; Piedrahita JA
Methods Mol Biol; 2015; 1330():69-78. PubMed ID: 26621590
[TBL] [Abstract][Full Text] [Related]
31. Generation and periodontal differentiation of human gingival fibroblasts-derived integration-free induced pluripotent stem cells.
Yin X; Li Y; Li J; Li P; Liu Y; Wen J; Luan Q
Biochem Biophys Res Commun; 2016 May; 473(3):726-32. PubMed ID: 26456649
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a Duchenne muscular dystrophy patient-derived induced pluripotent stem cell line carrying a deletion of exons 51-53 of the dystrophin gene (CCMi003-A).
Rovina D; Castiglioni E; Farini A; Bellichi M; Gervasini C; Paganini S; Di Segni M; Santoro R; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2019 Oct; 40():101544. PubMed ID: 31465894
[TBL] [Abstract][Full Text] [Related]
33. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
[TBL] [Abstract][Full Text] [Related]
34. Generation of non-integrated induced pluripotent stem cells from a 59-year-old female with multiple endocrine neoplasia type 1 syndrome.
Guo D; Wu F; Liu H; Gao G; Kou S; Yang F; Abbas N; Zhou T; Cai X; Zhang H; Qin D; Li J; Xu K; Li YX
Stem Cell Res; 2017 Jan; 18():64-66. PubMed ID: 28395808
[TBL] [Abstract][Full Text] [Related]
35. Clinical and genetic characteristics of Chinese patients with cerebrotendinous xanthomatosis.
Tao QQ; Zhang Y; Lin HX; Dong HL; Ni W; Wu ZY
Orphanet J Rare Dis; 2019 Dec; 14(1):282. PubMed ID: 31796091
[TBL] [Abstract][Full Text] [Related]
36. Generation of induced pluripotent stem cell (iPSC) line from Charcot-Marie-Tooth disease patient with MPZ mutation (CMT1B).
Son D; Kang PJ; Yun W; You S
Stem Cell Res; 2017 Oct; 24():5-7. PubMed ID: 29034895
[TBL] [Abstract][Full Text] [Related]
37. Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.
Suh S; Kim HK; Park HD; Ki CS; Kim MY; Jin SM; Kim SW; Hur KY; Kim KW; Kim JH
Eur J Med Genet; 2012 Jan; 55(1):71-4. PubMed ID: 21958693
[TBL] [Abstract][Full Text] [Related]
38. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
39. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
[TBL] [Abstract][Full Text] [Related]
40. Lymphoblast-derived integration-free ISRM-CON9 iPS cell line from a 75year old female.
Martins S; Bohndorf M; Schröter F; Assar F; Wruck W; Sleegers K; Van Broeckhoven C; Adjaye J
Stem Cell Res; 2018 Jan; 26():76-79. PubMed ID: 29268155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]